Pulmatrix Announces Publication Demonstrating Reduction of Bioaerosols with FEND, an OTC Nasal Hygiene Product Designed to Cleanse Airways of Airborne ParticlesPRNewsWire • 09/30/20
Pulmatrix's stock rockets after deal with Cipla Technologies to develop, commercialize asthma treatmentMarket Watch • 04/01/19